How does MediKane help address this critical global health concern? - Kalkine Media

Follow us on Google News:
 How does MediKane help address this critical global health concern?
Image source: © Jorgeantonio | Megapixl.com


  • MediKane’s flagship product NutriKane D is designed to help people live with rising or high blood sugar levels.
  • The company claims this product is formulated with natural ingredients that enhance insulin sensitivity, help in weight loss, lower the glycaemic index of foods, promote a healthy microbiome, and reduce systemic inflammation.
  • The International Diabetes Federation estimates the number of diabetes-affected people to peak 643 million by 2030 and 783 million by 2045.

Australia-based ‘Food-as-Medicine’ company MediKane is tapping vast opportunities in the health segment through its innovative natural products. The company has spent the last ten years building the foundations and is taking its innovations global.

MediKane has a long list of partners comprising Royal Melbourne Hospital, Royal North Shore Hospital, The University of Melbourne, Monash University, the Queensland University of Technology, Sydney University, Macquarie University, a hospital group in Chicago, USA, as well as several independent practitioners to fully establish the benefits of the product range under its brand NutriKane. 

The company says that the markets for its products are immense, global, and expanding. Its flagship product NutriKane D is meant to help people live with high blood sugar levels. It is a plant-based product assisting in weight loss and improving quality of life.

How big is the opportunity for NutriKane D?

Over many years, there has been incraese in the cases and prevalence of high blood sugar levels.

Here is a snapshot of the global scenario of diabetes in 2021 as per the International Diabetes Federation:

© 2022 Kalkine Media®, data source: www.idf.org


Types of diabetes

There are two main types of diabetes, namely Type 1 and Type 2. Only around 10% of all people with diabetes have type 1 diabetes, whereas Type 2 diabetes is the most common type. It accounts for about 90% of all diabetes cases. There are also other forms including gestational diabetes.

© Rob3000 | Megapixl.com

In Type 1 diabetes, the body’s defence system attacks insulin-producing cells. It is an autoimmune reaction in which there is very little or no insulin production by the body. The disease is related to a combination of genetic and environmental conditions.

The body does not completely respond to insulin in Type 2 diabetes. In this condition, insulin cannot work properly, causing blood glucose levels to rise, releasing more insulin. It is characterised by insulin resistance with higher levels of blood sugar.

Currently, for Type 1 diabetes, there is no prevention. Moreover, this subject is being assessed.  

The development of Type 2 diabetes is affected by several factors, in which lifestyle behaviours are the most common. These include the intake of unhealthy foods and inactive lifestyle. Multiple studies have shown that physical activities and a healthy diet can help prevent or delay the onset of Type 2 diabetes.  

NutriKane D, a food-based product, does not require regulation and registration as a pharmaceutical by Australia’s Therapeutic Goods Administration (TGA) or the US Food and Drug Administration (FDA).

Read here more about NutriKane D


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK